Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy

News

REQUITE on Facebook

"REQUITE cohort characteristics" paper is published open access

REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer is published open access in the Green Journal. The paper describes in detail the comprehensive centralised REQUITE database and linked biobank - a valuable resource for the radiotherapy community for validating predictive models and biomarkers.

Older news

Recruitment

Breast
2069
Lung
561
383*
Prostate
1808
* non-REQUITE patients included in our analyses

Events

ESTRO 38

The annual congress of ESTRO will take place 26-30 April 2019 in Milan, Italy. ESTRO 38 will offer all professionals of oncology the chance to share knowledge, practice and advances in the field, within the ever warm and dynamic environment of the ESTRO meetings. ‘Targeting optimal care, together’ will be the theme of ESTRO 38 and through these few, however impactful words, the Scientific and organising committees would like to put a spotlight on the multiprofessional and multidisciplinary aspect of our specialty. The theme also represents our strength: we are all working towards a common goal for improved patient outcomes, and this will be expressed throughout the scientific programme... See for more information the website

Dates: 
Friday, 26 April, 2019 to Tuesday, 30 April, 2019
Location: 
MiCo (Milano Congressi)
Viale Ludovico Scarampo - Fieramilanocity
20149 Milano
Italy
IT